For citations:
Balykova L.A., Stolyarova V.V., Orlova D.A., Shokina S.V., Esina M.V., Yamashkina E.I., Surina T.A., Zorina L.A., Shcherbakova V.S., Zaslavskaya K.Ya., Bely P.A. Evaluation of the effect of semaglutide on certain cardiovascular risk factors in overweight or obese healthcare workers. The “Start with yourself” program: a post-registration, single-center, prospective study of routine clinical practice. Pharmacy & Pharmacology. 2026;14(4):410-422. (In Russ.) https://doi.org/10.19163/2307-9266-2026-14-4-410-422
JATS XML


















































